B Group, Inc. Ultragenyx Pharmaceutical Inc. Transaction History
B Group, Inc.
- $117 Billion
- Q1 2025
A detailed history of B Group, Inc. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, B Group, Inc. holds 47,500 shares of RARE stock, worth $1.76 Million. This represents 1.47% of its overall portfolio holdings.
Number of Shares
47,500
Previous 7,596
525.33%
Holding current value
$1.76 Million
Previous $320 Million
438.23%
% of portfolio
1.47%
Previous 0.2%
Shares
2 transactions
Others Institutions Holding RARE
# of Institutions
336Shares Held
88.9MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$370 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$208 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$154 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$119 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$97 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.59B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...